246 related articles for article (PubMed ID: 26056182)
21. Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations.
Seow WJ; Matsuo K; Hsiung CA; Shiraishi K; Song M; Kim HN; Wong MP; Hong YC; Hosgood HD; Wang Z; Chang IS; Wang JC; Chatterjee N; Tucker M; Wei H; Mitsudomi T; Zheng W; Kim JH; Zhou B; Caporaso NE; Albanes D; Shin MH; Chung LP; An SJ; Wang P; Zheng H; Yatabe Y; Zhang XC; Kim YT; Shu XO; Kim YC; Bassig BA; Chang J; Ho JC; Ji BT; Kubo M; Daigo Y; Ito H; Momozawa Y; Ashikawa K; Kamatani Y; Honda T; Sakamoto H; Kunitoh H; Tsuta K; Watanabe SI; Nokihara H; Miyagi Y; Nakayama H; Matsumoto S; Tsuboi M; Goto K; Yin Z; Shi J; Takahashi A; Goto A; Minamiya Y; Shimizu K; Tanaka K; Wu T; Wei F; Wong JY; Matsuda F; Su J; Kim YH; Oh IJ; Song F; Lee VH; Su WC; Chen YM; Chang GC; Chen KY; Huang MS; Yang PC; Lin HC; Xiang YB; Seow A; Park JY; Kweon SS; Chen CJ; Li H; Gao YT; Wu C; Qian B; Lu D; Liu J; Jeon HS; Hsiao CF; Sung JS; Tsai YH; Jung YJ; Guo H; Hu Z; Wang WC; Chung CC; Lawrence C; Burdett L; Yeager M; Jacobs KB; Hutchinson A; Berndt SI; He X; Wu W; Wang J; Li Y; Choi JE; Park KH; Sung SW; Liu L; Kang CH; Hu L; Chen CH; Yang TY; Xu J; Guan P; Tan W; Wang CL; Sihoe AD; Chen Y; Choi YY; Hung JY; Kim JS; Yoon HI; Cai Q; Lin CC; Park IK; Xu P; Dong J; Kim C; He Q; Perng RP; Chen CY; Vermeulen R; Wu J; Lim WY; Chen KC; Chan JK; Chu M; Li YJ; Li J; Chen H; Yu CJ; Jin L; Lo YL; Chen YH; Fraumeni JF; Liu J; Yamaji T; Yang Y; Hicks B; Wyatt K; Li SA; Dai J; Ma H; Jin G; Song B; Wang Z; Cheng S; Li X; Ren Y; Cui P; Iwasaki M; Shimazu T; Tsugane S; Zhu J; Jiang G; Fei K; Wu G; Chien LH; Chen HL; Su YC; Tsai FY; Chen YS; Yu J; Stevens VL; Laird-Offringa IA; Marconett CN; Lin D; Chen K; Wu YL; Landi MT; Shen H; Rothman N; Kohno T; Chanock SJ; Lan Q
Hum Mol Genet; 2017 Jan; 26(2):454-465. PubMed ID: 28025329
[TBL] [Abstract][Full Text] [Related]
22. Protein-altering germline mutations implicate novel genes related to lung cancer development.
Ji X; Mukherjee S; Landi MT; Bosse Y; Joubert P; Zhu D; Gorlov I; Xiao X; Han Y; Gorlova O; Hung RJ; Brhane Y; Carreras-Torres R; Christiani DC; Caporaso N; Johansson M; Liu G; Bojesen SE; Le Marchand L; Albanes D; Bickeböller H; Aldrich MC; Bush WS; Tardon A; Rennert G; Chen C; Byun J; Dragnev KH; Field JK; Kiemeney LF; Lazarus P; Zienolddiny S; Lam S; Schabath MB; Andrew AS; Bertazzi PA; Pesatori AC; Diao N; Su L; Song L; Zhang R; Leighl N; Johansen JS; Mellemgaard A; Saliba W; Haiman C; Wilkens L; Fernandez-Somoano A; Fernandez-Tardon G; Heijden EHFMV; Kim JH; Davies MPA; Marcus MW; Brunnström H; Manjer J; Melander O; Muller DC; Overvad K; Trichopoulou A; Tumino R; Goodman GE; Cox A; Taylor F; Woll P; Wichmann E; Muley T; Risch A; Rosenberger A; Grankvist K; Johansson M; Shepherd F; Tsao MS; Arnold SM; Haura EB; Bolca C; Holcatova I; Janout V; Kontic M; Lissowska J; Mukeria A; Ognjanovic S; Orlowski TM; Scelo G; Swiatkowska B; Zaridze D; Bakke P; Skaug V; Butler LM; Offit K; Srinivasan P; Bandlamudi C; Hellmann MD; Solit DB; Robson ME; Rudin CM; Stadler ZK; Taylor BS; Berger MF; Houlston R; McLaughlin J; Stevens V; Nickle DC; Obeidat M; Timens W; Artigas MS; Shete S; Brenner H; Chanock S; Brennan P; McKay JD; Amos CI
Nat Commun; 2020 May; 11(1):2220. PubMed ID: 32393777
[TBL] [Abstract][Full Text] [Related]
23. Germline Mutations in DNA Repair Genes in Lung Adenocarcinoma.
Parry EM; Gable DL; Stanley SE; Khalil SE; Antonescu V; Florea L; Armanios M
J Thorac Oncol; 2017 Nov; 12(11):1673-1678. PubMed ID: 28843361
[TBL] [Abstract][Full Text] [Related]
24. hOGG1 Ser326Cys polymorphism and risk of lung cancer by histological type.
Okasaka T; Matsuo K; Suzuki T; Ito H; Hosono S; Kawase T; Watanabe M; Yatabe Y; Hida T; Mitsudomi T; Tanaka H; Yokoi K; Tajima K
J Hum Genet; 2009 Dec; 54(12):739-45. PubMed ID: 19881468
[TBL] [Abstract][Full Text] [Related]
25. Associations between clinical data and computed tomography features in patients with epidermal growth factor receptor mutations in lung adenocarcinoma.
Cao Y; Xu H; Liao M; Qu Y; Xu L; Zhu D; Wang B; Tian S
Int J Clin Oncol; 2018 Apr; 23(2):249-257. PubMed ID: 28988295
[TBL] [Abstract][Full Text] [Related]
26. KRAS mutation-positive bronchial surface epithelium (BSE)-type lung adenocarcinoma with strong expression of TTF-1: a case providing a further insight as for the role of TTF-1 in the oncogenesis.
Takanashi Y; Tajima S; Hayakawa T; Neyatani H; Funai K
Int J Clin Exp Pathol; 2015; 8(11):15338-43. PubMed ID: 26823891
[TBL] [Abstract][Full Text] [Related]
27. A low microRNA-630 expression confers resistance to tyrosine kinase inhibitors in EGFR-mutated lung adenocarcinomas via miR-630/YAP1/ERK feedback loop.
Wu DW; Wang YC; Wang L; Chen CY; Lee H
Theranostics; 2018; 8(5):1256-1269. PubMed ID: 29507618
[No Abstract] [Full Text] [Related]
28. Spectrum of gene mutations detected by next generation exome sequencing in brain metastases of lung adenocarcinoma.
Preusser M; Berghoff AS; Koller R; Zielinski CC; Hainfellner JA; Liebmann-Reindl S; Popitsch N; Geier CB; Streubel B; Birner P
Eur J Cancer; 2015 Sep; 51(13):1803-11. PubMed ID: 26164066
[TBL] [Abstract][Full Text] [Related]
29. The genomic alterations of lung adenocarcinoma and lung squamous cell carcinoma can explain the differences of their overall survival rates.
Meng F; Zhang L; Ren Y; Ma Q
J Cell Physiol; 2019 Jul; 234(7):10918-10925. PubMed ID: 30549039
[TBL] [Abstract][Full Text] [Related]
30. Relationships between EGFR mutation status of lung cancer and preoperative factors - are they predictive?
Usuda K; Sagawa M; Motono N; Ueno M; Tanaka M; Machida Y; Matoba M; Taniguchi M; Tonami H; Ueda Y; Sakuma T
Asian Pac J Cancer Prev; 2014; 15(2):657-62. PubMed ID: 24568474
[TBL] [Abstract][Full Text] [Related]
31. Identification of GALNT14 as a novel neuroblastoma predisposition gene.
De Mariano M; Gallesio R; Chierici M; Furlanello C; Conte M; Garaventa A; Croce M; Ferrini S; Tonini GP; Longo L
Oncotarget; 2015 Sep; 6(28):26335-46. PubMed ID: 26309160
[TBL] [Abstract][Full Text] [Related]
32. Lung cancer screening with low-dose computed tomography: Experiences from a tertiary hospital in Taiwan.
Chen CY; Chen CH; Shen TC; Cheng WC; Hsu CN; Liao CH; Chen CY; Hsia TC; Liao WC; Tu CY; Shih CM; Hsu WH
J Formos Med Assoc; 2016 Mar; 115(3):163-70. PubMed ID: 26714425
[TBL] [Abstract][Full Text] [Related]
33. Germline polymorphisms and survival of lung adenocarcinoma patients: a genome-wide study in two European patient series.
Galvan A; Colombo F; Frullanti E; Dassano A; Noci S; Wang Y; Eisen T; Matakidou A; Tomasello L; Vezzalini M; Sorio C; Dugo M; Ambrogi F; Iacobucci I; Martinelli G; Incarbone M; Alloisio M; Nosotti M; Tosi D; Santambrogio L; Pelosi G; Pastorino U; Houlston RS; Dragani TA
Int J Cancer; 2015 Mar; 136(5):E262-71. PubMed ID: 25196286
[TBL] [Abstract][Full Text] [Related]
34. Low angiomotin-p130 with concomitant high Yes-associated protein 1 expression is associated with adverse prognosis of advanced gastric cancer.
Hong SA; Son MW; Cho J; Jang SH; Lee HJ; Lee JH; Cho HD; Oh MH; Lee MS
APMIS; 2017 Nov; 125(11):996-1006. PubMed ID: 28885730
[TBL] [Abstract][Full Text] [Related]
35. Potential genetic modifiers for somatic EGFR mutation in lung cancer: a meta-analysis and literature review.
Cheng YI; Gan YC; Liu D; Davies MPA; Li WM; Field JK
BMC Cancer; 2019 Nov; 19(1):1068. PubMed ID: 31703574
[TBL] [Abstract][Full Text] [Related]
36. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations.
Lal G; Liu G; Schmocker B; Kaurah P; Ozcelik H; Narod SA; Redston M; Gallinger S
Cancer Res; 2000 Jan; 60(2):409-16. PubMed ID: 10667595
[TBL] [Abstract][Full Text] [Related]
37. Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status.
Pak MG; Lee CH; Lee WJ; Shin DH; Roh MS
Diagn Pathol; 2015 Jul; 10():99. PubMed ID: 26170125
[TBL] [Abstract][Full Text] [Related]
38. miR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer.
Nishikawa E; Osada H; Okazaki Y; Arima C; Tomida S; Tatematsu Y; Taguchi A; Shimada Y; Yanagisawa K; Yatabe Y; Toyokuni S; Sekido Y; Takahashi T
Cancer Res; 2011 Oct; 71(19):6165-73. PubMed ID: 21856745
[TBL] [Abstract][Full Text] [Related]
39. Familial lung adenocarcinoma caused by the EGFR V843I germ-line mutation.
Ohtsuka K; Ohnishi H; Kurai D; Matsushima S; Morishita Y; Shinonaga M; Goto H; Watanabe T
J Clin Oncol; 2011 Mar; 29(8):e191-2. PubMed ID: 21172876
[No Abstract] [Full Text] [Related]
40. EGFR and KRAS molecular genotyping for pulmonary carcinomas: Feasibility of a simple and rapid technique implementable in any department of pathology.
Thomas De Montpréville V; Ghigna MR; Lacroix L; Lemoine A; Besse B; Mercier O; Fadel É; Dorfmuller P; Le Chevalier T;
Pathol Res Pract; 2017 Jul; 213(7):793-798. PubMed ID: 28554746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
